RemeGen Co., Ltd. (HKG:9995)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
79.35
-0.90 (-1.12%)
Sep 22, 2026, 4:08 PM HKT

RemeGen Stock Forecast

Stock Price Forecast

According to 16 analysts polled by S&P Global, RemeGen stock has a consensus rating of "Buy" and an average price target of $117.36. The average 1-year stock price forecast is 47.90% higher than the current stock price, while the lowest is $89.70 (+13.04%) and the highest is $145.56 (+83.44%).

Price Target: $117.36 (+47.90%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$89.70$117.36$113.80$145.56
Change+13.04%+47.90%+43.42%+83.44%

Analyst Ratings

The average analyst rating for RemeGen stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingApr '26May '26Jun '26Jul '26Aug '26Sep '26
Strong Buy99891111
Buy443222
Hold444433
Sell000000
Strong Sell000000
Total171715151616

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Unknown Analyst
UBS
No rating
UBS
Buy
Maintains
$132.50
BuyMaintains$132.50+66.98%Sep 15, 2026
Unknown Analyst
CICC
No rating
CICC
Buy
Maintains
$112.92
BuyMaintains$112.92+42.31%Sep 1, 2026
Unknown Analyst
SPDB
No rating
SPDB
Buy
Maintains
$99.30
BuyMaintains$99.30+25.14%Aug 28, 2026
Unknown Analyst
Citi
No rating
Citi
Buy
Maintains
$105.00$127.70
BuyMaintains$105.00$127.70+60.93%Aug 26, 2026
Unknown Analyst
Bank of China
No rating
Bank of China
Buy
Maintains
$114.00
BuyMaintains$114.00+43.67%Aug 26, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
7.56B
from 3.25B
Increased by 132.51%
Revenue Next Year
4.46B
from 7.56B
Decreased by -40.97%
EPS This Year
7.66
from 1.29
Increased by 493.60%
EPS Next Year
1.26
from 7.66
Decreased by -83.53%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
1.42B772.11M1.08B1.72B3.25B7.56B
Revenue Growth
--45.78%40.26%58.54%89.36%132.51%
Gross Profit
1.36B500.06M825.68M1.37B2.84B7.06B
Gross Margin
95.28%64.77%76.24%79.81%87.22%93.34%
Operating Income
121.61M-1.19B-1.55B-1.42B139.86M4.55B
Net Income
276.26M-998.83M-1.51B-1.47B709.65M4.10B
EPS
----1.297.66
EPS Growth
-----493.60%
Forward PE
-----8.85
Free Cash Flow
-----147.42M3.38B
No. Analysts
-----3
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High8.2B
Avg7.6B
Low7.5B

Revenue Growth

Revenue Growth202620272028
High
153.3%
Avg
132.5%
Low
130.4%

EPS Forecast

EPS202620272028
High9.60
Avg7.66
Low6.58

EPS Growth

EPS Growth202620272028
High
644.2%
Avg
493.6%
Low
409.8%